Monitoring adenoviral p53 transduction efficiency by yeast functional assay View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1998-03-01

AUTHORS

M Tada, S Sakuma, RD Iggo, H Saya, Y Sawamura, T Fujiwara, JA Roth

ABSTRACT

Monitoring the transduction efficiency is of paramount importance in gene therapy. To monitor adenovirus-mediated wild-type p53 gene transfer, we have used a quantitative assay which tests the ability of human p53 to activate transcription in yeast. Selective amplification of cellular and viral p53 transcripts followed by quantitative assessment of mutant p53 content with the assay permits measurement of the wild-type p53 transduction efficiency into SF-188, U251MG and HUG31 glioblastoma cells. One reverse transcription primer tracks the wild-type/mutant ratio of endogenous p53 mRNA (P2), and the other the wild-type/mutant ratio of both endogenous and exogenous p53 mRNA (P1). Following infection of cell lines homozygous for mutant p53, the apparent transduction efficiency calculated (τ0 = [P1 − P2]/[1 + P2]) correlated with the level of p21 expression. Transduction efficiency in heterozygous wild-type/mutant HUG31 cells increased linearly with multiplicity of infection (MOI) for τ0 values between 0.5 and 5.9, and admixture of normal cell-derived RNA produced only a modest reduction in τ0 value, in keeping with theoretical predictions. These results suggest that the yeast p53 functional assay may be a useful tool for monitoring p53 gene therapy. More... »

PAGES

339-344

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.gt.3300605

DOI

http://dx.doi.org/10.1038/sj.gt.3300605

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1051323252

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9614553


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenoviridae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blotting, Northern", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclin-Dependent Kinase Inhibitor p21", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genes, p53", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Vectors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Messenger", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transduction, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Suppressor Protein p53", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Yeasts", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, Hokkaido University School of Medicine, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.39158.36", 
          "name": [
            "Department of Neurosurgery, Hokkaido University School of Medicine, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tada", 
        "givenName": "M", 
        "id": "sg:person.0621552724.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621552724.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, Hokkaido University School of Medicine, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.39158.36", 
          "name": [
            "Department of Neurosurgery, Hokkaido University School of Medicine, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sakuma", 
        "givenName": "S", 
        "id": "sg:person.01305120533.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305120533.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oncogene Group, Swiss Institute for Experimental Cancer Research, Epalinges/Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.5333.6", 
          "name": [
            "Oncogene Group, Swiss Institute for Experimental Cancer Research, Epalinges/Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iggo", 
        "givenName": "RD", 
        "id": "sg:person.01140527651.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140527651.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Tumor Genetics and Biology, Kumamoto University School of Medicine, Kumamoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.274841.c", 
          "name": [
            "Department of Tumor Genetics and Biology, Kumamoto University School of Medicine, Kumamoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saya", 
        "givenName": "H", 
        "id": "sg:person.0704677621.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704677621.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, Hokkaido University School of Medicine, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.39158.36", 
          "name": [
            "Department of Neurosurgery, Hokkaido University School of Medicine, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sawamura", 
        "givenName": "Y", 
        "id": "sg:person.01253610572.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253610572.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Department of Surgery, Okayama University, Okayama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.261356.5", 
          "name": [
            "First Department of Surgery, Okayama University, Okayama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fujiwara", 
        "givenName": "T", 
        "id": "sg:person.012002625555.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012002625555.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roth", 
        "givenName": "JA", 
        "id": "sg:person.010016607062.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010016607062.27"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.onc.1200812", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011707970", 
          "https://doi.org/10.1038/sj.onc.1200812"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998-03-01", 
    "datePublishedReg": "1998-03-01", 
    "description": "Monitoring the transduction efficiency is of paramount importance in gene therapy. To monitor adenovirus-mediated wild-type p53 gene transfer, we have used a quantitative assay which tests the ability of human p53 to activate transcription in yeast. Selective amplification of cellular and viral p53 transcripts followed by quantitative assessment of mutant p53 content with the assay permits measurement of the wild-type p53 transduction efficiency into SF-188, U251MG and HUG31 glioblastoma cells. One reverse transcription primer tracks the wild-type/mutant ratio of endogenous p53 mRNA (P2), and the other the wild-type/mutant ratio of both endogenous and exogenous p53 mRNA (P1). Following infection of cell lines homozygous for mutant p53, the apparent transduction efficiency calculated (\u03c40\u2009=\u2009[P1\u2009\u2212\u2009P2]/[1\u2009+\u2009P2]) correlated with the level of p21 expression. Transduction efficiency in heterozygous wild-type/mutant HUG31 cells increased linearly with multiplicity of infection (MOI) for \u03c40 values between 0.5 and 5.9, and admixture of normal cell-derived RNA produced only a modest reduction in \u03c40 value, in keeping with theoretical predictions. These results suggest that the yeast p53 functional assay may be a useful tool for monitoring p53 gene therapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.gt.3300605", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1105638", 
        "issn": [
          "0969-7128", 
          "1476-5462"
        ], 
        "name": "Gene Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "transduction efficiency", 
      "multiplicity of infection", 
      "p53 mRNA", 
      "yeast functional assay", 
      "mutant ratio", 
      "human p53", 
      "wild-type p53 gene transfer", 
      "gene transfer", 
      "functional assays", 
      "glioblastoma cells", 
      "SF-188", 
      "gene therapy", 
      "mutant p53", 
      "reverse transcription primers", 
      "cell lines", 
      "p21 expression", 
      "p53 transcripts", 
      "p53", 
      "selective amplification", 
      "p53 gene transfer", 
      "transcription primers", 
      "mRNA", 
      "p53 content", 
      "exogenous p53 mRNA", 
      "cells", 
      "assays", 
      "transcription", 
      "yeast", 
      "transcripts", 
      "RNA", 
      "primers", 
      "U251MG", 
      "p53 gene therapy", 
      "expression", 
      "useful tool", 
      "adenovirus", 
      "amplification", 
      "lines", 
      "infection", 
      "efficiency", 
      "admixture", 
      "modest reduction", 
      "paramount importance", 
      "ability", 
      "importance", 
      "levels", 
      "content", 
      "quantitative assessment", 
      "\u03c40 values", 
      "transfer", 
      "tool", 
      "multiplicity", 
      "results", 
      "ratio", 
      "reduction", 
      "prediction", 
      "therapy", 
      "theoretical predictions", 
      "measurements", 
      "values", 
      "assessment", 
      "endogenous p53 mRNA"
    ], 
    "name": "Monitoring adenoviral p53 transduction efficiency by yeast functional assay", 
    "pagination": "339-344", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1051323252"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.gt.3300605"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9614553"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.gt.3300605", 
      "https://app.dimensions.ai/details/publication/pub.1051323252"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-06-01T22:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_291.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.gt.3300605"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3300605'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3300605'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3300605'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3300605'


 

This table displays all metadata directly associated to this object as RDF triples.

242 TRIPLES      22 PREDICATES      104 URIs      95 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.gt.3300605 schema:about N068be011ea66459abdb0275aba7c37d0
2 N0944a29db83c4f85a9ea160e67c9b02c
3 N0b616fe9bb3546418cfb8954d9e63719
4 N15759467ec3f4dadb9cb3640f71c86a6
5 N353954b755c54350b024b6941e6c4d72
6 N5142dc98021e40c18d58c5c5dfc02095
7 N5b7e0ad2bbeb4eddbe794d6438788711
8 N7098d9a50a08407ab423445c043641ea
9 N811b7ab0ea824e0a8be6b4b8ffb30c79
10 N8e5263487d9346c2bf458a89f06256f3
11 N909b8fda8f2f49fe9358e3984ef30703
12 N933bab175d304002b29d54ff7dc09c2f
13 Naecfe6a534a943d88ac30544fd3614bb
14 Nd6ce04c0b1144660b3a07efd67b81657
15 Nfb6b8b84b43442be815cfe007679c94b
16 anzsrc-for:06
17 anzsrc-for:11
18 schema:author N98a0a1d7fc2e4572aeb90e465f7e6a0f
19 schema:citation sg:pub.10.1038/sj.onc.1200812
20 schema:datePublished 1998-03-01
21 schema:datePublishedReg 1998-03-01
22 schema:description Monitoring the transduction efficiency is of paramount importance in gene therapy. To monitor adenovirus-mediated wild-type p53 gene transfer, we have used a quantitative assay which tests the ability of human p53 to activate transcription in yeast. Selective amplification of cellular and viral p53 transcripts followed by quantitative assessment of mutant p53 content with the assay permits measurement of the wild-type p53 transduction efficiency into SF-188, U251MG and HUG31 glioblastoma cells. One reverse transcription primer tracks the wild-type/mutant ratio of endogenous p53 mRNA (P2), and the other the wild-type/mutant ratio of both endogenous and exogenous p53 mRNA (P1). Following infection of cell lines homozygous for mutant p53, the apparent transduction efficiency calculated (τ0 = [P1 − P2]/[1 + P2]) correlated with the level of p21 expression. Transduction efficiency in heterozygous wild-type/mutant HUG31 cells increased linearly with multiplicity of infection (MOI) for τ0 values between 0.5 and 5.9, and admixture of normal cell-derived RNA produced only a modest reduction in τ0 value, in keeping with theoretical predictions. These results suggest that the yeast p53 functional assay may be a useful tool for monitoring p53 gene therapy.
23 schema:genre article
24 schema:inLanguage en
25 schema:isAccessibleForFree true
26 schema:isPartOf N380f11c880e54d34aee5e531af9b006c
27 Nbda79afdcfb64f8592c07f43b580b0ab
28 sg:journal.1105638
29 schema:keywords RNA
30 SF-188
31 U251MG
32 ability
33 adenovirus
34 admixture
35 amplification
36 assays
37 assessment
38 cell lines
39 cells
40 content
41 efficiency
42 endogenous p53 mRNA
43 exogenous p53 mRNA
44 expression
45 functional assays
46 gene therapy
47 gene transfer
48 glioblastoma cells
49 human p53
50 importance
51 infection
52 levels
53 lines
54 mRNA
55 measurements
56 modest reduction
57 multiplicity
58 multiplicity of infection
59 mutant p53
60 mutant ratio
61 p21 expression
62 p53
63 p53 content
64 p53 gene therapy
65 p53 gene transfer
66 p53 mRNA
67 p53 transcripts
68 paramount importance
69 prediction
70 primers
71 quantitative assessment
72 ratio
73 reduction
74 results
75 reverse transcription primers
76 selective amplification
77 theoretical predictions
78 therapy
79 tool
80 transcription
81 transcription primers
82 transcripts
83 transduction efficiency
84 transfer
85 useful tool
86 values
87 wild-type p53 gene transfer
88 yeast
89 yeast functional assay
90 τ0 values
91 schema:name Monitoring adenoviral p53 transduction efficiency by yeast functional assay
92 schema:pagination 339-344
93 schema:productId N3a4063e0bdc24be7b69a1ba5f0b25fa8
94 N74a9fd41c539481894b780d09de004e3
95 N7a765fe634694e6f99e09cccec9acf49
96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051323252
97 https://doi.org/10.1038/sj.gt.3300605
98 schema:sdDatePublished 2022-06-01T22:02
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher Nedbe3d20b95c41f287539b57834c0992
101 schema:url https://doi.org/10.1038/sj.gt.3300605
102 sgo:license sg:explorer/license/
103 sgo:sdDataset articles
104 rdf:type schema:ScholarlyArticle
105 N068be011ea66459abdb0275aba7c37d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Cyclin-Dependent Kinase Inhibitor p21
107 rdf:type schema:DefinedTerm
108 N0944a29db83c4f85a9ea160e67c9b02c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Humans
110 rdf:type schema:DefinedTerm
111 N0b616fe9bb3546418cfb8954d9e63719 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Cyclins
113 rdf:type schema:DefinedTerm
114 N15759467ec3f4dadb9cb3640f71c86a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Gene Expression
116 rdf:type schema:DefinedTerm
117 N1794109ae4c34ac49a745a725d6419e3 rdf:first sg:person.01140527651.89
118 rdf:rest N1b3d6d80c218438eb89ad6b856c52e35
119 N1b3d6d80c218438eb89ad6b856c52e35 rdf:first sg:person.0704677621.52
120 rdf:rest Nfc4fd913efe3413ca95498b35792f549
121 N33da6b4aed1a481b88edadb396b9c8a5 rdf:first sg:person.01305120533.80
122 rdf:rest N1794109ae4c34ac49a745a725d6419e3
123 N353954b755c54350b024b6941e6c4d72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Polymerase Chain Reaction
125 rdf:type schema:DefinedTerm
126 N380f11c880e54d34aee5e531af9b006c schema:issueNumber 3
127 rdf:type schema:PublicationIssue
128 N3a4063e0bdc24be7b69a1ba5f0b25fa8 schema:name dimensions_id
129 schema:value pub.1051323252
130 rdf:type schema:PropertyValue
131 N5142dc98021e40c18d58c5c5dfc02095 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Blotting, Northern
133 rdf:type schema:DefinedTerm
134 N5b7e0ad2bbeb4eddbe794d6438788711 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Tumor Cells, Cultured
136 rdf:type schema:DefinedTerm
137 N7098d9a50a08407ab423445c043641ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Genes, p53
139 rdf:type schema:DefinedTerm
140 N74a9fd41c539481894b780d09de004e3 schema:name doi
141 schema:value 10.1038/sj.gt.3300605
142 rdf:type schema:PropertyValue
143 N7a765fe634694e6f99e09cccec9acf49 schema:name pubmed_id
144 schema:value 9614553
145 rdf:type schema:PropertyValue
146 N811b7ab0ea824e0a8be6b4b8ffb30c79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Transduction, Genetic
148 rdf:type schema:DefinedTerm
149 N8e5263487d9346c2bf458a89f06256f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Adenoviridae
151 rdf:type schema:DefinedTerm
152 N909b8fda8f2f49fe9358e3984ef30703 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Genetic Vectors
154 rdf:type schema:DefinedTerm
155 N933bab175d304002b29d54ff7dc09c2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name RNA, Messenger
157 rdf:type schema:DefinedTerm
158 N98a0a1d7fc2e4572aeb90e465f7e6a0f rdf:first sg:person.0621552724.43
159 rdf:rest N33da6b4aed1a481b88edadb396b9c8a5
160 Naecfe6a534a943d88ac30544fd3614bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Yeasts
162 rdf:type schema:DefinedTerm
163 Nbb83552b4f7e4fc28c8fa4415ccadb1e rdf:first sg:person.010016607062.27
164 rdf:rest rdf:nil
165 Nbda79afdcfb64f8592c07f43b580b0ab schema:volumeNumber 5
166 rdf:type schema:PublicationVolume
167 Nd6ce04c0b1144660b3a07efd67b81657 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Tumor Suppressor Protein p53
169 rdf:type schema:DefinedTerm
170 Nedbe3d20b95c41f287539b57834c0992 schema:name Springer Nature - SN SciGraph project
171 rdf:type schema:Organization
172 Nefa3df51004f4804bedc3c6e095f8cf5 rdf:first sg:person.012002625555.31
173 rdf:rest Nbb83552b4f7e4fc28c8fa4415ccadb1e
174 Nfb6b8b84b43442be815cfe007679c94b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Enzyme Inhibitors
176 rdf:type schema:DefinedTerm
177 Nfc4fd913efe3413ca95498b35792f549 rdf:first sg:person.01253610572.82
178 rdf:rest Nefa3df51004f4804bedc3c6e095f8cf5
179 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
180 schema:name Biological Sciences
181 rdf:type schema:DefinedTerm
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 sg:journal.1105638 schema:issn 0969-7128
186 1476-5462
187 schema:name Gene Therapy
188 schema:publisher Springer Nature
189 rdf:type schema:Periodical
190 sg:person.010016607062.27 schema:affiliation grid-institutes:grid.240145.6
191 schema:familyName Roth
192 schema:givenName JA
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010016607062.27
194 rdf:type schema:Person
195 sg:person.01140527651.89 schema:affiliation grid-institutes:grid.5333.6
196 schema:familyName Iggo
197 schema:givenName RD
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140527651.89
199 rdf:type schema:Person
200 sg:person.012002625555.31 schema:affiliation grid-institutes:grid.261356.5
201 schema:familyName Fujiwara
202 schema:givenName T
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012002625555.31
204 rdf:type schema:Person
205 sg:person.01253610572.82 schema:affiliation grid-institutes:grid.39158.36
206 schema:familyName Sawamura
207 schema:givenName Y
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253610572.82
209 rdf:type schema:Person
210 sg:person.01305120533.80 schema:affiliation grid-institutes:grid.39158.36
211 schema:familyName Sakuma
212 schema:givenName S
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305120533.80
214 rdf:type schema:Person
215 sg:person.0621552724.43 schema:affiliation grid-institutes:grid.39158.36
216 schema:familyName Tada
217 schema:givenName M
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621552724.43
219 rdf:type schema:Person
220 sg:person.0704677621.52 schema:affiliation grid-institutes:grid.274841.c
221 schema:familyName Saya
222 schema:givenName H
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704677621.52
224 rdf:type schema:Person
225 sg:pub.10.1038/sj.onc.1200812 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011707970
226 https://doi.org/10.1038/sj.onc.1200812
227 rdf:type schema:CreativeWork
228 grid-institutes:grid.240145.6 schema:alternateName Department of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Houston, TX, USA
229 schema:name Department of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Houston, TX, USA
230 rdf:type schema:Organization
231 grid-institutes:grid.261356.5 schema:alternateName First Department of Surgery, Okayama University, Okayama, Japan
232 schema:name First Department of Surgery, Okayama University, Okayama, Japan
233 rdf:type schema:Organization
234 grid-institutes:grid.274841.c schema:alternateName Department of Tumor Genetics and Biology, Kumamoto University School of Medicine, Kumamoto, Japan
235 schema:name Department of Tumor Genetics and Biology, Kumamoto University School of Medicine, Kumamoto, Japan
236 rdf:type schema:Organization
237 grid-institutes:grid.39158.36 schema:alternateName Department of Neurosurgery, Hokkaido University School of Medicine, Sapporo, Japan
238 schema:name Department of Neurosurgery, Hokkaido University School of Medicine, Sapporo, Japan
239 rdf:type schema:Organization
240 grid-institutes:grid.5333.6 schema:alternateName Oncogene Group, Swiss Institute for Experimental Cancer Research, Epalinges/Lausanne, Switzerland
241 schema:name Oncogene Group, Swiss Institute for Experimental Cancer Research, Epalinges/Lausanne, Switzerland
242 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...